On 14 March 2024, the National Development and Reform Commission("NDRC") of the People's Republic of China ("PRC") issued theCircular on Supporting Quality Enterprises to Borrow Medium-and Long-term Foreign Debts to Promote Quality Development of the Real Economy (Draft for Comments)(the "Draft Circular")(《国家发展改革委关于支持优质企业借用中长期外债 促进实体经济高质量发展的通知(征求意见稿)》) to solicit public opinion from 14 March 2024 to 13 April 2024...
Han Kun Law Offices
Main Contacts
Offices
Overview
Han Kun is a leading full-service law firm in China. Over the years, Han Kun has been widely recognized as a leader in complex cross-border and domestic transactions and compliance matters.
Our main practice areas include private equity, mergers and acquisitions, international and domestic capital markets, investment funds, asset management, compliance, banking and finance, aviation finance, foreign direct investment, antitrust/competition, data protection, private client/wealth management, intellectual property, bankruptcy and restructuring and dispute resolution.
We have over 800 professionals located in Beijing, Shanghai, Shenzhen, Hong Kong, Haikou, Wuhan, Singapore and New York City.
All our lawyers are graduates of top universities and have extensive experience in complex cross-border transactions and dispute resolution as counsel to both Chinese and foreign clients.
Year this Office was Established: 2004
Lawyers Worldwide: 800
Areas of Practice
Professionals
Partners
Yijun Chao
PartnerXianglin Chen
PartnerDafei Chen
PartnerRong (Estella) Chen
PartnerYang Chen
PartnerXiaoming Deng
PartnersZhichao(Kevin) Duan
PartnerMin Duan
PartnerRong Fang
PartnerLin Gui
PartnerYang Han
PartnerChunyan He
PartnerYanlei He
PartnerJun He
PartnerRui Huang
PartnerDongni Jiang
PartnersWenyu Jin
PartnerTao Lan
PartnerSHENG LI
PartnerWEI (DAVID) LI
PartnerShijia LI
PartnerChaoying (Charles) Li
PartnerXiaoming Li
PartnerJiajia(Loretta) Li
PartnerZhuowei (Joyce) Li
PartnerJing Li
PartnerYing Li
PartnersYipu Li
PartnersBaofu Li
PartnerYixin Lin
PartnerJiaxin LIU
PartnerXiayi Liu
PartnerRuina Liu
PartnerRuijie (Rae) Liu
PartnerDong (Eric) Liu
PartnerJing Liu
PartnerLong Liu
PartnerZaiguang LU
PartnerLifeng Lu
PartnerRui LUO
PartnerShaolin Luo
PartnerChen Ma
PartnerXiu Pei
PartnerLu Ran
PartnerRong (Reese) Rong (Reese)
PartnerJing (Gilbert) Shen
PartnersDa Shi
PartnersLei (Ray) Shi
PartnerHaining Song
PartnerShu WANG
PartnerJin Wang
PartnerXin (Gloria) Wang
PartnerXikang Wang
PartnerQi Wang
PartnerXiaowei WEI
PartnerLili WU
PartnerKaiying WU
PartnerShipo (Angus) Xie
PartnersYing (Gloria) XU
PartnerYing YANG
PartnerTiecheng YANG
PartnerYang You
PartnerLan Yu
PartnerShiye Yuan
PartnerLiming Yuan
PartnerTao ZHANG
PartnerJian Zhang
PartnerYaxing Zhang
PartnerZhao Zhang
PartnerZhihan Zhao
PartnerPei Zhao
PartnerBin ZHI
PartnerYing (Tracy) ZHOU
PartnerLin ZHOU
PartnerChengyao(Aaron) ZHOU
PartnerJun ZHU
PartnerQimin(Rebecca) Zhu
PartnerAssociates
Of Counsel
Han Chen
CounselJunfeng Cui
Of CounselJie (Jessie) Dong
Of CounselCencen (Miko) Feng
Of CounselXiao Guo
Of CounselZhehao Li
Of CounselQian Li
Of CounselJingbo Luo
Of CounselBing San
Of CounselYikai Wang
Of CounselZhenyu Wang
Of CounselYichen Wu
Of CounselYing Zeng
Of CounselQi Zhang
Of CounselXinfeng Zhang
Of CounselYuxuan Zhang
Of CounselYunzhi Zhao
Of CounselOther
Xiaomeng Dong
Manager of trademark application departmentSara Shao
Business Development ManagerTongyi Wang
MarketingJenny Xu
MarketingNancy Huang
Head of Research DepartmentArticles
2022-23 Data Analysis on China Life Sciences Licensing Key Terms
In recent years, license-in/out transactions have become the most common way for innovative drugs and medical devices (including medical aesthetics) companies to collaboratively develop and commercialize medical products and related technologies. According to public information, in China, the total amount and number of investment and financing in life sciences sector have witnessed a significant decline from 2021 to 2023, with the investment amount being only a quarter of that in 2021. However, the upfront payment for business development (BD) transactions in life sciences sector has reached 5.045 billion US dollars in 2023, with a potential payment totaling up to 54...
Press
Han Kun provides legal services for the listing of SigmaStar Technology Ltd. on the ChiNext Board.
Han Kun provided legal services for the initial public offering and listing of SigmaStar Technology Ltd. ("SigmaStar Technology", stock code: 301536) on the ChiNext Board. Han Kun acted as the legal advisor for the sponsor.SigmaStar Technology is a world-leading video surveillance chip company, especially in the field of intelligent security, video intercom, and intelligent vehicles, in which it has significant market positions. The company focuses on consumer electronics, security, Internet of Things, and multimedia artificial intelligence chips, and its products cover IP cams, USB cams, NVR, DVR, vehicle electronics, action cameras, smart home, and smart displays...
Han Kun Authors the China Chapter of The Legal 500's Country Comparative Guides for Life Sciences
The Legal 500, the world-renowned legal media, recently published its 2024 Country Comparative Guides. Each country chapter of the Guides is written in an easy-to-use Q&A format by a renowned firm within the specified legal practice area. Han Kun Law Offices exclusively contributed the China chapter of the Country Comparative Guides for Life Sciences, and the contributors include Han Kun partners Chengyao (Aaron) Zhou, Liming Yuan, Min Zhu, and Yang (Aaron) Gu...